TBC II LLC

RICHMOND, VA · Founded 2015 · CIK 0001672736 · Biotech

Biological neural computing systems integrating live neurons into AI models for improved performance and reduced computational cost

tbc.co →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3.5M
2 Form D · Dec 2018
93 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,520,000
Private capital raisedForm D · SEC$566,270
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1877Addex Therapeutics Ltd.—$14M
1878STEMBIOSYS, INC.—$3.4M
1879Prince Biotech, Inc.—$10M
1880TBC II LLC—$3.5M
1881Cardiol Therapeutics Inc.—$6.0M
1882IMMUNO NANO MED, INC——
1883MycoRx LLC—$600K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • A. Ewing, IIIExecutive Officer
  • Mark MurrayExecutive Officer
  • Thomas WillinghamExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.